Presented by Charissa Duffy, DNP, MSN, PMHNP-BC, and Tana Whitt, PMHNP-BC. Breakfast will be provided. Attendees will be admitted on a first-come basis. This interactive, case-based session examines the differentiation of drug-induced movement disorders and the clinical presentation of tardive dyskinesia (TD) in older adults. Attendees will explore the functional impacts of TD, learn the importance of regular TD screening, and hear about evidence-based treatment strategies. Special focus will be given to the clinical application of approved therapies, including VMAT2 inhibitors, to support informed treatment selection and enhance patient care. Supported by Neurocrine Biosciences, Inc.